Purdue Pharma Inc. Sustainability Profile
Purdue Pharma Inc., a prominent player in the pharmaceutical industry, is headquartered in California and operates extensively across North America. Founded in 1892, the company has a rich history marked by significant milestones, including the development of innovative pain management solutions. Purdue Pharma is best known for its unique formulations of prescription medications, particularly in the realm of pain relief. Their flagship product, OxyContin, revolutionised the treatment of chronic pain, although it has also been the subject of considerable scrutiny. With a strong market position, Purdue Pharma continues to focus on advancing therapeutic options while navigating the complexities of the healthcare landscape. The company remains committed to addressing the needs of patients and healthcare providers through its ongoing research and development efforts.
DitchCarbon Score
How does Purdue Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Purdue Pharma Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Purdue Pharma Inc.'s reported carbon emissions
Purdue Pharma Inc., headquartered in California, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is classified as a current subsidiary, and any emissions data or climate commitments may be inherited from its parent organisation. However, no specific details regarding emissions or climate initiatives have been provided. As a current subsidiary, Purdue Pharma Inc. may align with broader industry standards and practices, but without concrete data or commitments, it is challenging to assess its individual climate impact or goals. The absence of emissions data and reduction initiatives suggests that the company may still be in the process of developing its climate strategy or reporting framework.
How Carbon Intensive is Purdue Pharma Inc.'s Industry?
How Carbon Intensive is Purdue Pharma Inc.'s Location?
Purdue Pharma Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Purdue Pharma Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
